Concepts (246)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Alcohol Drinking | 10 | 2021 | 288 | 2.560 |
Why?
|
Ethanol | 12 | 2021 | 306 | 1.960 |
Why?
|
Alcoholism | 10 | 2020 | 308 | 1.880 |
Why?
|
Prefrontal Cortex | 6 | 2018 | 107 | 1.540 |
Why?
|
Rats | 26 | 2021 | 1909 | 1.280 |
Why?
|
Rats, Wistar | 18 | 2021 | 179 | 1.170 |
Why?
|
Myelin Sheath | 2 | 2018 | 34 | 1.070 |
Why?
|
Sex Characteristics | 5 | 2021 | 197 | 1.040 |
Why?
|
Hippocampus | 5 | 2021 | 246 | 0.830 |
Why?
|
Receptors, Corticotropin-Releasing Hormone | 7 | 2016 | 24 | 0.750 |
Why?
|
Limbic System | 1 | 2021 | 27 | 0.740 |
Why?
|
Corticotropin-Releasing Hormone | 7 | 2016 | 34 | 0.740 |
Why?
|
Interleukin-1beta | 2 | 2021 | 256 | 0.730 |
Why?
|
Self Administration | 11 | 2021 | 46 | 0.720 |
Why?
|
Conditioning, Operant | 6 | 2021 | 26 | 0.720 |
Why?
|
Hypothalamo-Hypophyseal System | 4 | 2015 | 88 | 0.700 |
Why?
|
Gyrus Cinguli | 2 | 2018 | 55 | 0.700 |
Why?
|
Toll-Like Receptor 4 | 1 | 2021 | 338 | 0.660 |
Why?
|
Testosterone | 5 | 2004 | 112 | 0.650 |
Why?
|
Gonadotropin-Releasing Hormone | 3 | 2004 | 86 | 0.640 |
Why?
|
Binge Drinking | 2 | 2021 | 27 | 0.640 |
Why?
|
Neural Conduction | 1 | 2018 | 29 | 0.610 |
Why?
|
Corpus Callosum | 1 | 2018 | 40 | 0.600 |
Why?
|
Action Potentials | 1 | 2018 | 101 | 0.590 |
Why?
|
Axons | 1 | 2018 | 118 | 0.580 |
Why?
|
Animals | 34 | 2021 | 19601 | 0.550 |
Why?
|
Central Nervous System Depressants | 5 | 2009 | 42 | 0.500 |
Why?
|
Stress, Psychological | 4 | 2016 | 442 | 0.470 |
Why?
|
Male | 32 | 2021 | 27727 | 0.450 |
Why?
|
Pyrimidines | 6 | 2016 | 130 | 0.440 |
Why?
|
Anxiety | 4 | 2012 | 387 | 0.430 |
Why?
|
White Matter | 1 | 2014 | 114 | 0.430 |
Why?
|
Amygdala | 3 | 2015 | 78 | 0.420 |
Why?
|
Prosencephalon | 2 | 2004 | 37 | 0.420 |
Why?
|
RNA, Messenger | 6 | 2021 | 1464 | 0.410 |
Why?
|
Neurogenesis | 2 | 2009 | 60 | 0.380 |
Why?
|
Neuroglia | 2 | 2009 | 79 | 0.380 |
Why?
|
Sexual Maturation | 3 | 2004 | 50 | 0.330 |
Why?
|
Alcohol-Induced Disorders, Nervous System | 1 | 2008 | 1 | 0.310 |
Why?
|
Endocrine System Diseases | 1 | 2008 | 10 | 0.310 |
Why?
|
Nervous System | 1 | 2008 | 69 | 0.290 |
Why?
|
Anti-Anxiety Agents | 1 | 2007 | 31 | 0.290 |
Why?
|
Age Factors | 4 | 2018 | 1504 | 0.280 |
Why?
|
Pheromones | 2 | 2004 | 22 | 0.280 |
Why?
|
Luteinizing Hormone | 2 | 2004 | 98 | 0.280 |
Why?
|
Pituitary-Adrenal System | 3 | 2015 | 60 | 0.260 |
Why?
|
Cell Proliferation | 2 | 2009 | 940 | 0.250 |
Why?
|
Dose-Response Relationship, Drug | 7 | 2016 | 806 | 0.250 |
Why?
|
Cell Count | 3 | 2012 | 127 | 0.250 |
Why?
|
Behavior, Addictive | 4 | 2020 | 72 | 0.230 |
Why?
|
Feedback, Physiological | 1 | 2004 | 59 | 0.220 |
Why?
|
Female | 14 | 2021 | 30695 | 0.210 |
Why?
|
Brain | 6 | 2015 | 1487 | 0.200 |
Why?
|
Quantitative Trait, Heritable | 2 | 2014 | 26 | 0.200 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2006 | 618 | 0.200 |
Why?
|
Disease Models, Animal | 7 | 2016 | 2046 | 0.200 |
Why?
|
Substance Withdrawal Syndrome | 3 | 2009 | 119 | 0.190 |
Why?
|
Neurons | 3 | 2016 | 863 | 0.190 |
Why?
|
Mesocricetus | 5 | 2004 | 93 | 0.190 |
Why?
|
Receptors, Glucocorticoid | 2 | 2015 | 27 | 0.190 |
Why?
|
Behavior, Animal | 6 | 2008 | 215 | 0.180 |
Why?
|
Cricetinae | 5 | 2004 | 365 | 0.180 |
Why?
|
Administration, Inhalation | 3 | 2009 | 145 | 0.170 |
Why?
|
Rats, Inbred Strains | 3 | 2015 | 150 | 0.170 |
Why?
|
Adrenocorticotropic Hormone | 3 | 2009 | 19 | 0.160 |
Why?
|
Avoidance Learning | 2 | 2016 | 23 | 0.160 |
Why?
|
Patch-Clamp Techniques | 1 | 2018 | 126 | 0.150 |
Why?
|
Methamphetamine | 2 | 2008 | 22 | 0.150 |
Why?
|
Gene Expression Regulation | 3 | 2021 | 1547 | 0.140 |
Why?
|
Neurosecretory Systems | 2 | 2008 | 24 | 0.140 |
Why?
|
Central Amygdaloid Nucleus | 1 | 2016 | 5 | 0.130 |
Why?
|
Hyperalgesia | 1 | 2016 | 12 | 0.130 |
Why?
|
Cost of Illness | 1 | 2017 | 156 | 0.130 |
Why?
|
Nicotine | 2 | 2007 | 113 | 0.130 |
Why?
|
Depression | 2 | 2012 | 828 | 0.120 |
Why?
|
Prenatal Exposure Delayed Effects | 2 | 2008 | 151 | 0.120 |
Why?
|
Sexual Behavior, Animal | 3 | 2004 | 87 | 0.120 |
Why?
|
Gene Regulatory Networks | 1 | 2015 | 146 | 0.110 |
Why?
|
Glucocorticoids | 1 | 2015 | 179 | 0.110 |
Why?
|
Naltrexone | 3 | 2009 | 77 | 0.110 |
Why?
|
Adolescent | 3 | 2020 | 5822 | 0.110 |
Why?
|
Cognitive Dysfunction | 1 | 2017 | 309 | 0.100 |
Why?
|
Evoked Potentials, Visual | 1 | 2012 | 13 | 0.100 |
Why?
|
Brain Waves | 1 | 2012 | 6 | 0.100 |
Why?
|
Visual Cortex | 1 | 2012 | 27 | 0.100 |
Why?
|
Bromodeoxyuridine | 2 | 2009 | 40 | 0.100 |
Why?
|
gamma-Aminobutyric Acid | 1 | 2012 | 70 | 0.100 |
Why?
|
Sex Factors | 2 | 2006 | 935 | 0.100 |
Why?
|
Anhedonia | 1 | 2012 | 6 | 0.100 |
Why?
|
Ki-67 Antigen | 2 | 2009 | 34 | 0.100 |
Why?
|
Food Preferences | 2 | 2009 | 50 | 0.100 |
Why?
|
Nerve Fibers | 1 | 2012 | 29 | 0.100 |
Why?
|
Corticosterone | 2 | 2008 | 22 | 0.100 |
Why?
|
Neuropeptides | 2 | 2009 | 83 | 0.100 |
Why?
|
Microtubule-Associated Proteins | 2 | 2009 | 109 | 0.090 |
Why?
|
Drug Administration Schedule | 2 | 2008 | 283 | 0.090 |
Why?
|
Quality of Life | 1 | 2017 | 1137 | 0.090 |
Why?
|
Mice | 3 | 2020 | 10251 | 0.080 |
Why?
|
Pregnancy | 2 | 2008 | 2202 | 0.080 |
Why?
|
Cell Death | 2 | 2008 | 271 | 0.080 |
Why?
|
Microdialysis | 1 | 2009 | 5 | 0.080 |
Why?
|
Stress, Physiological | 2 | 2015 | 185 | 0.080 |
Why?
|
Fluoresceins | 1 | 2009 | 29 | 0.080 |
Why?
|
Rats, Sprague-Dawley | 2 | 2008 | 574 | 0.080 |
Why?
|
Injections, Intravenous | 1 | 2009 | 155 | 0.080 |
Why?
|
Awards and Prizes | 1 | 2009 | 31 | 0.080 |
Why?
|
Nipples | 1 | 2009 | 14 | 0.080 |
Why?
|
Organic Chemicals | 1 | 2009 | 22 | 0.080 |
Why?
|
Heroin | 1 | 2009 | 12 | 0.080 |
Why?
|
Triazines | 1 | 2009 | 16 | 0.080 |
Why?
|
Depressive Disorder | 1 | 2012 | 279 | 0.080 |
Why?
|
Heroin Dependence | 1 | 2009 | 22 | 0.080 |
Why?
|
Long-Term Potentiation | 1 | 2009 | 42 | 0.080 |
Why?
|
Signal Transduction | 2 | 2016 | 2888 | 0.080 |
Why?
|
Mastectomy | 1 | 2009 | 52 | 0.080 |
Why?
|
Carcinoma, Ductal, Breast | 1 | 2009 | 45 | 0.080 |
Why?
|
Atrial Fibrillation | 1 | 2017 | 805 | 0.080 |
Why?
|
Catechol O-Methyltransferase | 1 | 2008 | 7 | 0.080 |
Why?
|
Paraventricular Hypothalamic Nucleus | 1 | 2008 | 20 | 0.080 |
Why?
|
Caspase 3 | 1 | 2009 | 103 | 0.080 |
Why?
|
Mammaplasty | 1 | 2009 | 43 | 0.080 |
Why?
|
Hearing | 1 | 2008 | 30 | 0.080 |
Why?
|
Feminization | 1 | 2008 | 1 | 0.080 |
Why?
|
Dentate Gyrus | 1 | 2008 | 11 | 0.080 |
Why?
|
Cocaine | 1 | 2009 | 96 | 0.080 |
Why?
|
Septal Nuclei | 1 | 2009 | 51 | 0.070 |
Why?
|
Alcohol Deterrents | 1 | 2008 | 6 | 0.070 |
Why?
|
Deafness | 1 | 2008 | 32 | 0.070 |
Why?
|
Thiophenes | 1 | 2008 | 29 | 0.070 |
Why?
|
Central Nervous System Stimulants | 1 | 2008 | 63 | 0.070 |
Why?
|
Environment | 1 | 2008 | 119 | 0.070 |
Why?
|
Cell Survival | 1 | 2009 | 559 | 0.070 |
Why?
|
Physical Conditioning, Animal | 1 | 2007 | 38 | 0.070 |
Why?
|
Reproduction | 2 | 2004 | 89 | 0.070 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2009 | 299 | 0.070 |
Why?
|
Data Interpretation, Statistical | 1 | 2008 | 191 | 0.070 |
Why?
|
Narcotic Antagonists | 1 | 2008 | 121 | 0.070 |
Why?
|
Genomics | 1 | 2009 | 318 | 0.070 |
Why?
|
Ligands | 1 | 2007 | 410 | 0.070 |
Why?
|
Pregnancy, Animal | 1 | 2006 | 9 | 0.060 |
Why?
|
Immunohistochemistry | 1 | 2008 | 846 | 0.060 |
Why?
|
Steroids | 1 | 2006 | 53 | 0.060 |
Why?
|
Diet | 1 | 2009 | 497 | 0.060 |
Why?
|
Cell Differentiation | 2 | 2008 | 1298 | 0.060 |
Why?
|
Time Factors | 3 | 2009 | 3614 | 0.060 |
Why?
|
Humans | 10 | 2020 | 59282 | 0.060 |
Why?
|
Smell | 1 | 2004 | 26 | 0.060 |
Why?
|
Models, Statistical | 1 | 2006 | 298 | 0.060 |
Why?
|
Gonadal Steroid Hormones | 1 | 2004 | 30 | 0.060 |
Why?
|
Seminal Vesicles | 1 | 2004 | 8 | 0.060 |
Why?
|
3,4-Dihydroxyphenylacetic Acid | 1 | 2003 | 5 | 0.060 |
Why?
|
Preoptic Area | 1 | 2003 | 50 | 0.050 |
Why?
|
Tobacco Use Disorder | 1 | 2006 | 243 | 0.050 |
Why?
|
Testis | 1 | 2004 | 135 | 0.050 |
Why?
|
Dopamine | 1 | 2003 | 102 | 0.050 |
Why?
|
Orchiectomy | 1 | 2002 | 28 | 0.050 |
Why?
|
Histocytochemistry | 1 | 2002 | 47 | 0.050 |
Why?
|
Silver | 1 | 2002 | 13 | 0.050 |
Why?
|
Body Weight | 1 | 2004 | 368 | 0.050 |
Why?
|
Androgens | 1 | 2002 | 47 | 0.050 |
Why?
|
Puberty | 1 | 2002 | 58 | 0.050 |
Why?
|
Quantitative Trait Loci | 2 | 2014 | 70 | 0.050 |
Why?
|
In Situ Hybridization | 1 | 2002 | 213 | 0.050 |
Why?
|
Tissue Distribution | 1 | 2002 | 287 | 0.050 |
Why?
|
Species Specificity | 2 | 2014 | 328 | 0.050 |
Why?
|
Analysis of Variance | 2 | 2016 | 589 | 0.050 |
Why?
|
Regression Analysis | 1 | 2002 | 485 | 0.050 |
Why?
|
Sexual Behavior | 1 | 2002 | 189 | 0.040 |
Why?
|
Breast Neoplasms | 1 | 2009 | 1118 | 0.040 |
Why?
|
Genetic Predisposition to Disease | 2 | 2015 | 673 | 0.040 |
Why?
|
Phenotype | 2 | 2014 | 1136 | 0.040 |
Why?
|
Mecamylamine | 2 | 2007 | 14 | 0.030 |
Why?
|
Surveys and Questionnaires | 2 | 2017 | 2511 | 0.030 |
Why?
|
Infusions, Intraventricular | 1 | 2016 | 9 | 0.030 |
Why?
|
Feeding Behavior | 2 | 2009 | 254 | 0.030 |
Why?
|
Odorants | 1 | 2016 | 17 | 0.030 |
Why?
|
Pain Threshold | 1 | 2016 | 25 | 0.030 |
Why?
|
Rats, Inbred BN | 1 | 2015 | 25 | 0.030 |
Why?
|
Databases, Nucleic Acid | 1 | 2015 | 8 | 0.030 |
Why?
|
Drug Tolerance | 1 | 2015 | 29 | 0.030 |
Why?
|
Craving | 1 | 2015 | 35 | 0.030 |
Why?
|
Neural Pathways | 1 | 2015 | 95 | 0.030 |
Why?
|
Pain Measurement | 1 | 2016 | 327 | 0.030 |
Why?
|
Recombination, Genetic | 1 | 2015 | 238 | 0.030 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2015 | 262 | 0.030 |
Why?
|
Choice Behavior | 1 | 2014 | 78 | 0.030 |
Why?
|
Recurrence | 1 | 2015 | 602 | 0.030 |
Why?
|
Prevalence | 1 | 2017 | 1252 | 0.030 |
Why?
|
Functional Neuroimaging | 1 | 2012 | 14 | 0.030 |
Why?
|
Glutamine | 1 | 2012 | 46 | 0.020 |
Why?
|
Glutamic Acid | 1 | 2012 | 95 | 0.020 |
Why?
|
Genotype | 1 | 2014 | 617 | 0.020 |
Why?
|
Transcriptome | 1 | 2015 | 338 | 0.020 |
Why?
|
Severity of Illness Index | 1 | 2017 | 1479 | 0.020 |
Why?
|
Anisotropy | 1 | 2012 | 58 | 0.020 |
Why?
|
Follow-Up Studies | 1 | 2017 | 2337 | 0.020 |
Why?
|
Diffusion Tensor Imaging | 1 | 2012 | 69 | 0.020 |
Why?
|
Brain Mapping | 1 | 2012 | 228 | 0.020 |
Why?
|
Prospective Studies | 1 | 2017 | 3065 | 0.020 |
Why?
|
Excitatory Amino Acid Antagonists | 1 | 2009 | 30 | 0.020 |
Why?
|
Adult | 3 | 2012 | 15663 | 0.020 |
Why?
|
Case-Control Studies | 1 | 2012 | 1051 | 0.020 |
Why?
|
Microarray Analysis | 1 | 2009 | 60 | 0.020 |
Why?
|
Brain Chemistry | 1 | 2009 | 77 | 0.020 |
Why?
|
Depressive Disorder, Major | 1 | 2012 | 245 | 0.020 |
Why?
|
Hair Cells, Auditory, Outer | 1 | 2008 | 1 | 0.020 |
Why?
|
Organ of Corti | 1 | 2008 | 4 | 0.020 |
Why?
|
Hair Cells, Auditory, Inner | 1 | 2008 | 5 | 0.020 |
Why?
|
Drinking Behavior | 1 | 2008 | 9 | 0.020 |
Why?
|
Receptors, Opioid | 1 | 2008 | 14 | 0.020 |
Why?
|
Blood-Brain Barrier | 1 | 2009 | 81 | 0.020 |
Why?
|
Cochlea | 1 | 2008 | 22 | 0.020 |
Why?
|
Mice, Inbred C3H | 1 | 2008 | 173 | 0.020 |
Why?
|
Injections, Intraventricular | 1 | 2008 | 18 | 0.020 |
Why?
|
Nebulizers and Vaporizers | 1 | 2008 | 36 | 0.020 |
Why?
|
Glial Fibrillary Acidic Protein | 1 | 2008 | 36 | 0.020 |
Why?
|
Saccharin | 1 | 2008 | 1 | 0.020 |
Why?
|
Duloxetine Hydrochloride | 1 | 2008 | 3 | 0.020 |
Why?
|
Pedigree | 1 | 2008 | 183 | 0.020 |
Why?
|
Hydrocortisone | 1 | 2009 | 187 | 0.020 |
Why?
|
Adult Stem Cells | 1 | 2008 | 28 | 0.020 |
Why?
|
Point Mutation | 1 | 2008 | 160 | 0.020 |
Why?
|
Sweetening Agents | 1 | 2008 | 21 | 0.020 |
Why?
|
Aged, 80 and over | 1 | 2017 | 5128 | 0.020 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2009 | 438 | 0.020 |
Why?
|
Self Stimulation | 1 | 2006 | 2 | 0.020 |
Why?
|
Sensory Thresholds | 1 | 2006 | 5 | 0.020 |
Why?
|
Cotinine | 1 | 2006 | 19 | 0.020 |
Why?
|
Nicotinic Antagonists | 1 | 2006 | 19 | 0.020 |
Why?
|
Gene Expression Profiling | 1 | 2009 | 716 | 0.020 |
Why?
|
Emotions | 1 | 2008 | 214 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2009 | 1189 | 0.020 |
Why?
|
Reward | 1 | 2006 | 83 | 0.020 |
Why?
|
Amino Acid Sequence | 1 | 2008 | 1552 | 0.020 |
Why?
|
Molecular Sequence Data | 1 | 2008 | 1949 | 0.010 |
Why?
|
Stress Disorders, Post-Traumatic | 1 | 2009 | 380 | 0.010 |
Why?
|
Castration | 1 | 2004 | 41 | 0.010 |
Why?
|
United States | 1 | 2017 | 7385 | 0.010 |
Why?
|
Sex Differentiation | 1 | 2004 | 9 | 0.010 |
Why?
|
Progesterone | 1 | 2004 | 158 | 0.010 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2003 | 225 | 0.010 |
Why?
|
Estradiol | 1 | 2004 | 247 | 0.010 |
Why?
|
Young Adult | 1 | 2012 | 4266 | 0.010 |
Why?
|
Hormones | 1 | 2002 | 60 | 0.010 |
Why?
|
Aged | 1 | 2017 | 13412 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2008 | 3220 | 0.010 |
Why?
|